Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building, Room 6B05 ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 2 contracts
Sources: Contract (Acambis PLC), Contract (Seracare Life Sciences Inc)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building, Room 6B05 [***] ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇[***] BETHESDA MD 20892-▇▇▇▇ 7540 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Isis Pharmaceuticals Inc)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I, the cognizant Contracting Officer representative representative' responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building▇▇▇▇ ▇▇▇▇▇▇▇▇, Room 6B05 ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Paradigm Genetics Inc)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Back to Contents Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building▇▇▇▇ ▇▇▇▇▇▇▇▇, Room 6B05 ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Indirect Cost Rates. a. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part PART II, Section SECTION I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building, Room 6B05 [*] AMCG ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ., ▇.▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ . Room G640 Washington, D.C. 20201
b. These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Pfenex Inc.)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(27(d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building, Room 6B05 ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇, MD 20892-▇▇▇▇ 7540 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Vaxgen Inc)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1I) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building6▇▇▇ ▇▇▇▇▇▇▇▇, Room 6B05 ▇6▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Acambis PLC)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part PART II, Section SECTION I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building6▇▇▇ ▇▇▇▇▇▇▇▇, Room 6B05 ▇6▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ These rates are hereby incorporated without further action of the Contracting Officer.▇
Appears in 1 contract
Sources: Contract (Genvec Inc)
Indirect Cost Rates. a. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part PART II, Section SECTION I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building, Room 6B05 ▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ AMCG ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ., ▇.▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ . Room G640 Washington, D.C. 20201
b. These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Pfenex Inc.)
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section I1, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 6100 Building▇▇▇▇ ▇▇▇▇▇▇▇▇, Room 6B05 ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇-▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇ ▇▇▇▇▇-▇▇▇▇ These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Sources: Contract (Pharmathene, Inc)